Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Increased dietary intake of Selenium (Se) has been suggested to lower prostate cancer mortality, but supplementation trials have produced conflicting results. Se is incorporated into 25 selenoproteins. The aim of this work was to assess whether risk of prostate cancer is affected by genetic variants...
Guardado en:
Autores principales: | Catherine Méplan, Sabine Rohrmann, Astrid Steinbrecher, Lutz Schomburg, Eugène Jansen, Jakob Linseisen, John Hesketh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f9227011a9b4196bdeb5cf04a6024e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P
por: Kostja Renko, et al.
Publicado: (2017) -
Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk.
por: Catherine Méplan, et al.
Publicado: (2013) -
Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
por: Xuping Wu, et al.
Publicado: (2021) -
Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.
por: Hellmuth A Meyer, et al.
Publicado: (2012) -
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death
por: Shibo Sun, et al.
Publicado: (2021)